Default company panoramic image
Logo

S1 Biopharma

S1 Biopharma is a clinical-stage biopharmaceutical developer specializing in therapeutic soultions for disorders of sexual health

  • Stage Concept Only
  • Industry Biotechnology
  • Location Jersey City, NJ, USA
  • Currency USD
  • Founded June 2008
  • Website s1biopharma.com

Company Summary

S1 Biopharma is a market‐focused company specializing in the discovery, development, and commercialization of drug therapies for Hypoactive Sexual Desire Disorder (HSDD) and related Sexual Dysfunctions. S1’s lead product, Lorexys, is an oral drug seeking to be the first safe and effective treatment approved by the FDA for HSDD in women. Additional products in development will seek to be the first approved for related Sexual Dysfunctions.

Team

  • Default avatar
    Nick Sitchon
    Chief Executive Officer

  • Default avatar
    Robert Pyke
    Chief Medical Officer

  • Default avatar
    John Kaufmann
    Chief Financial Officer

Advisors

  • Default avatar
    Edwards Wildman Palmer
    Lawyer
    Unconfirmed
    Default avatar
    WithumSmith+Brown
    Accountant
    Unconfirmed